Next Gen Biotech

Vectibix 100mg injection is an anticancer drug belonging to the class of epidermal growth factor receptor (EGFR) inhibitors, containing the active ingredient Panitumumab. It is used to treat metastatic colorectal cancer (cancer that begins in the colon or rectum and has spread to other parts of the body).

It is not recommended to take this injection if you are allergic to any of its ingredients. This drug targets certain proteins in the body, which can increase the risk of bleeding. If you experience any signs of bleeding while taking this drug, such as unusual bleeding or bruising, black or tarry stools, blood in the urine, or bleeding gums, you should contact your doctor immediately. Your doctor may need to adjust your dose or temporarily stop the treatment. Eye problems can occur while on the treatment with this medicine such as inflammation and damage to the cornea, and the symptoms may include eye pain, redness, blurred vision, and sensitivity to light.

It is important to tell your doctor if you experience any skin problems while taking this medicine. Your doctor may recommend topical creams or ointments to soothe the skin or antibiotics to treat any infections that may develop. Infusion reactions can happen as a side effect of this drug, which are allergic reactions that can occur during or shortly after the infusion of the medication. To minimize the risk of infusion reactions, your doctor will monitor you closely during and after the infusion and may give you medications such as antihistamines and corticosteroids to prevent or treat any allergic reactions that may occur. Vectibix 100mg injection is not recommended during pregnancy as it causes harm to the unborn baby. Tell your healthcare provider before beginning this treatment if you are pregnant or planning to have a baby. It is advised for both men and women to follow proper contraceptive methods during and for 3 months after the last dose of the drug.

Vectibix 100mg injection is an anticancer drug belonging to the class of epidermal growth factor receptor (EGFR) inhibitors, containing the active ingredient Panitumumab. It is used to treat metastatic colorectal cancer (cancer that begins in the colon or rectum and has spread to other parts of the body).

It is not recommended to take this injection if you are allergic to any of its ingredients. This drug targets certain proteins in the body, which can increase the risk of bleeding. If you experience any signs of bleeding while taking this drug, such as unusual bleeding or bruising, black or tarry stools, blood in the urine, or bleeding gums, you should contact your doctor immediately. Your doctor may need to adjust your dose or temporarily stop the treatment. Eye problems can occur while on the treatment with this medicine such as inflammation and damage to the cornea, and the symptoms may include eye pain, redness, blurred vision, and sensitivity to light.

It is important to tell your doctor if you experience any skin problems while taking this medicine. Your doctor may recommend topical creams or ointments to soothe the skin or antibiotics to treat any infections that may develop. Infusion reactions can happen as a side effect of this drug, which are allergic reactions that can occur during or shortly after the infusion of the medication. To minimize the risk of infusion reactions, your doctor will monitor you closely during and after the infusion and may give you medications such as antihistamines and corticosteroids to prevent or treat any allergic reactions that may occur. Vectibix 100mg injection is not recommended during pregnancy as it causes harm to the unborn baby. Tell your healthcare provider before beginning this treatment if you are pregnant or planning to have a baby. It is advised for both men and women to follow proper contraceptive methods during and for 3 months after the last dose of the drug.